WEIGHT: 59 kg
Services: Fetish, Oral Without (at discretion), Cunnilingus, Deep throating, Domination (giving)
Search Filters. Trial Filters. A listing of Burgas, Bulgaria clinical trials actively recruiting patients volunteers. This is a randomized, open-label, multicenter Phase 3 study in adult patients with histologically confirmed, locally advanced or metastatic Stage IIIB or IV , NSCLC squamous or non-squamous who have disease progression during or after a platinum-containing regimen.
Aortic dissection AD is the surging of blood through a tear in the aortic intima with separation of the intima and media and creation of a false lumen. The dissection may occur anywhere along the aorta and extend proximally or distally into other arteries. It occurs most commonly at the This is an open label, prospective, non-randomised, multi-centre first-in-human evaluation of the Vetex Thrombectomy Device for treatment of acute iliofemoral deep vein thrombosis DVT.
MINC03 is a 6-week, 3-arm, randomized, double-blind, placebo-controlled study to investigate the safety and efficacy of MIN in male and female patients with Major Depressive Disorder, aged 18 to 65 years. Approximately patients will be randomly assigned to 1 of 3 treatment arms, including placebo, 5. A study to evaluate the efficacy of 2 fixed-flexible doses of Lu AF on negative symptoms in patients with schizophrenia.
The study will evaluate the efficacy and safety of ITI adjunctive to lithium or valproate in a randomized, double-blind, parallel-group, placebo-controlled, multi-center study in patients diagnosed with Bipolar I or Bipolar II disorder having a major depressive episode. SURE-AVR objective is to collect post market safety and performance data collected along the procedure and the relevant follow-up with Sorin Group aortic valve devices in accordance with the IFU to further evidence the safety and efficacy in a post-approval environment.
All current and future Sorin Group aortic valve devices MINC07 is a multicenter, multinational, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of roluperidone in adult schizophrenia patients. The primary objective is to evaluate the efficacy of 2 fixed doses of roluperidone compared to placebo in improving the negative symptoms of schizophrenia over 12 weeks of double-blind A phase III, dose-ranging, multi-centre, randomised, double-blind, placebo controlled , home-use, parallel group clinical trial of topically applied glyceryl trinitrate for the treatment of erectile dysfunction with an open label extension.